This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT05629585
Brief Title: A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)

First Submitted : November 4, 2022
First Submitted that Met QC Criteria : November 17, 2022
First Posted : November 29, 2022

Last Update Submitted that Met QC Criteria : February 12, 2024
Last Update Posted : February 13, 2024